ACON vs BDSX: stock comparison and AI forecast
Aclarion, Inc. (ACON) and Biodesix Inc (BDSX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACON Aclarion, Inc.
- Market Cap
- $4M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
BDSX Biodesix Inc
- Market Cap
- $90M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BDSX is 20.0 times larger than ACON by market capitalization ($90M against $4M).
- BDSX carries 9.83 times debt per unit of equity, against 0.07 times for ACON.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACON | BDSX |
|---|---|---|
| Market Cap | $4M | $90M |
| P/B Ratio | 0.30x | 10.37x |
| EPS | $-11.31 | $-2.57 |
| Book Value/Share | $5.13 | $0.82 |
| Revenue/Share | $0.04 | $9.97 |
| FCF/Share | – | $-1.81 |
Profitability & Margins
| Metric | ACON | BDSX |
|---|---|---|
| ROE | – | -312.1% |
| ROA | – | -28.8% |
| ROIC | -81.9% | -24.7% |
| Gross Margin | 20.5% | – |
| Operating Margin | -10315.4% | -18.7% |
| Net Margin | – | -25.7% |
| EBT Margin | -10335.8% | -18.7% |
| Tax Rate | 0.0% | 0.0% |
Financial Health
| Metric | ACON | BDSX |
|---|---|---|
| Current Ratio | 14.17x | 2.96x |
| D/E Ratio | 0.07x | 9.83x |
| Financial Leverage | 1.07x | 10.83x |
| Interest Coverage | -3.8x | -6.1x |
| Working Capital | $14M | $28M |
Cash Flow
| Metric | ACON | BDSX |
|---|---|---|
| Operating Cash Flow | -$9M | -$18M |
| Free Cash Flow | – | -$19M |
| Capital Spending | – | -$920K |
| FCF/Sales | – | -18.1% |
| CapEx/Sales | – | 0.9% |
Operational Efficiency
| Metric | ACON | BDSX |
|---|---|---|
| Asset Turnover | 0.01x | 1.12x |
| Receivables Turnover | 3.5x | 11.5x |
| Fixed Assets Turnover | 5.4x | 4.5x |
| Days Sales Outstanding | 103 days | 32 days |
| Payables Period | 925 days | – |
Income Statement
| Metric | ACON | BDSX |
|---|---|---|
| Total Revenue | $120K | $105M |
| Operating Income | -$12M | -$20M |
| Net Income | – | -$27M |
| R&D Expense | $1M | $12M |
| SG&A Expense | $12M | $94M |
| Cost of Goods Sold | $90K | – |
Dividend & Shareholder Information
| Metric | ACON | BDSX |
|---|---|---|
| Shares Outstanding | 3M | 11M |
ACON vs BDSX: stock comparison and AI forecast
Which is bigger, ACON or BDSX?
BDSX is 20.0 times larger than ACON by market capitalization ($90M against $4M).
Which one does Intratio's AI model rank higher, ACON or BDSX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.